News | February 28, 2023
Sanofi reaffirms commitment to rare diseases in India
Receives Subject Expert Committee recommendation to bring new therapies of Pompe, ASMD to India
Receives Subject Expert Committee recommendation to bring new therapies of Pompe, ASMD to India
This artificial RNA ligase has higher thermostability than natural RNA ligase
According to GlobalData’s analyst consensus forecast, OTX-2002 is projected to have the highest revenue by 2028, with sales of $1.6 billion during that year
OmiCrisp has been developed with support from Centre for Cellular And Molecular Platforms C-CAMP-InDx Program
This will give either party customers access enzyme expertise and assets, resulting in cost-effective, green processing for API manufacturing.
OriCiro's synthetic biology and enzyme technologies will support Moderna's expanding portfolio of therapeutics and vaccines
To create leading company developing medicines targeting metalloenzymes
To focus on providing safer burn treatments for women and armed forces
Tambe has been with Biocon since 1997 and has held diverse leadership and operational roles.
Viehbacher brings extensive international experience in large pharmaceutical and entrepreneurial biotech companies
Subscribe To Our Newsletter & Stay Updated
